Paclitaxel Plus Radiation With Erlotinib to Treat Esophageal Squamous Carcinoma

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The purpose of this study is to test the safety and effectiveness of erlotinib and chemoradiotherapy in patients with unresectable esophageal or gastro-esophageal squamous cancer .
Epistemonikos ID: 1ed139625cdbc7af0b6e18eb9b26d9f02c2beeb5
First added on: May 11, 2024